Cargando…
Everolimus associated interstitial pneumonitis in a liver transplant patient
Drug-induced interstitial lung disease is associated with significant morbidity and mortality. Everolimus is an inhibitor of mTOR, a mammalian target of rapamycin, used as an immunosuppressant agent in solid organ transplant. Everolimus has been associated with interstitial lung disease in solid org...
Autores principales: | Siddiqui, Atif S., Zimmerman, Janice L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919724/ https://www.ncbi.nlm.nih.gov/pubmed/27366673 http://dx.doi.org/10.1016/j.rmcr.2016.06.004 |
Ejemplares similares
-
Everolimus induced pneumonitis in a lung transplant recipient
por: Arunachalam, Ambalavanan, et al.
Publicado: (2018) -
Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
por: Sibertin-Blanc, Camille, et al.
Publicado: (2013) -
Docetaxel-related interstitial pneumonitis
por: Wang, Chung-Jen, et al.
Publicado: (2015) -
Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient
por: Patel, Serena, et al.
Publicado: (2018) -
A Fatal Case of Life-Threatening Interstitial Pneumonitis Induced by Everolimus for Metastatic Renal Cell Carcinoma: A Comment about the Increased Risk of Interstitial Lung Disease in Japanese
por: Murakami, Yasukiyo, et al.
Publicado: (2019)